Mast cell deficiency prevents BCR::ABL1 induced splenomegaly and cytokine elevation in a CML mouse model
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: 10.1038/s41375-023-01916-x
- Event
-
Veröffentlichung
- (where)
-
Aachen
- (who)
-
Universitätsbibliothek der RWTH Aachen
- (when)
-
2023
- Creator
-
Langhammer, Melanie
Schöpf, Julia
Jaquet, Timo
Horn, Katharina
Angel, Moritz
Spohr, Corinna
Christen, Daniel
Uhl, Franziska Maria
Maié, Tiago
Jacobi, Henrike
Feyerabend, Thorsten B.
Huber, Julia
Panning, Marcus
Sitaru, Cassian
Costa Filho, Ivan Gesteira
Zeiser, Robert
Aumann, Konrad
Becker, Heiko
Braunschweig, Till
Koschmieder, Steffen
Shoumariyeh, Khalid
Huber, Michael
Schemionek-Reinders, Mirle
Brummer, Tilman
Halbach, Sebastian
- DOI
-
10.18154/RWTH-CONV-252200
- URN
-
urn:nbn:de:101:1-2405260132460.821406376139
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:56 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Langhammer, Melanie
- Schöpf, Julia
- Jaquet, Timo
- Horn, Katharina
- Angel, Moritz
- Spohr, Corinna
- Christen, Daniel
- Uhl, Franziska Maria
- Maié, Tiago
- Jacobi, Henrike
- Feyerabend, Thorsten B.
- Huber, Julia
- Panning, Marcus
- Sitaru, Cassian
- Costa Filho, Ivan Gesteira
- Zeiser, Robert
- Aumann, Konrad
- Becker, Heiko
- Braunschweig, Till
- Koschmieder, Steffen
- Shoumariyeh, Khalid
- Huber, Michael
- Schemionek-Reinders, Mirle
- Brummer, Tilman
- Halbach, Sebastian
- Universitätsbibliothek der RWTH Aachen
Time of origin
- 2023
Other Objects (12)
Mast cell deficiency prevents BCR::ABL1 induced splenomegaly and cytokine elevation in a CML mouse model
Phosphorylation of Beclin 1 by BCR-ABL suppresses autophagy in CML
Advances in understanding the pathogenesis of graft‐versus‐host disease
Intestinal microbiota influence immune tolerance post allogeneic hematopoietic cell transplantation and intestinal GVHD
Editorial: Non-coding RNAs and graft versus host disease
Chimeric antigen receptor T cells for acute myeloid leukemia
Immunomodulatory therapies for the treatment of graft-versus-host disease
Immunotherapy in myeloproliferative diseases
The role of the MDM2/p53 axis in anti-tumor immune responses
Kinase inhibition as treatment for acute and chronic graft-versus-host disease
Editorial: Current concepts of cellular and biological drugs to modulate regulatory T cell activity in the clinic, volume II
FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation
Mast cell deficiency prevents BCR::ABL1 induced splenomegaly and cytokine elevation in a CML mouse model
Phosphorylation of Beclin 1 by BCR-ABL suppresses autophagy in CML
Advances in understanding the pathogenesis of graft‐versus‐host disease
Intestinal microbiota influence immune tolerance post allogeneic hematopoietic cell transplantation and intestinal GVHD
Editorial: Non-coding RNAs and graft versus host disease
Chimeric antigen receptor T cells for acute myeloid leukemia
Immunomodulatory therapies for the treatment of graft-versus-host disease
Immunotherapy in myeloproliferative diseases
The role of the MDM2/p53 axis in anti-tumor immune responses
Kinase inhibition as treatment for acute and chronic graft-versus-host disease
Editorial: Current concepts of cellular and biological drugs to modulate regulatory T cell activity in the clinic, volume II
FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation
Mast cell deficiency prevents BCR::ABL1 induced splenomegaly and cytokine elevation in a CML mouse model
Phosphorylation of Beclin 1 by BCR-ABL suppresses autophagy in CML
Advances in understanding the pathogenesis of graft‐versus‐host disease
Intestinal microbiota influence immune tolerance post allogeneic hematopoietic cell transplantation and intestinal GVHD
Editorial: Non-coding RNAs and graft versus host disease
Chimeric antigen receptor T cells for acute myeloid leukemia
Immunomodulatory therapies for the treatment of graft-versus-host disease
Immunotherapy in myeloproliferative diseases
The role of the MDM2/p53 axis in anti-tumor immune responses
Kinase inhibition as treatment for acute and chronic graft-versus-host disease
Editorial: Current concepts of cellular and biological drugs to modulate regulatory T cell activity in the clinic, volume II